Pharmaceutical

FDA committee proposes overhaul of perioperative lung cancer trials 

The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.

Jul 28, 2024 - 04:00
FDA committee proposes overhaul of perioperative lung cancer trials 
The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.
Read the original article

Tags:

Previous Article

Balancing instability and robustness: new mathematical framework to understand d...

Next Article

EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Why hospitals are cutting ties with Moody’s rating agency

STAT+: Why hospitals are cutting ties with Moody’s rati...

Jul 14, 2023

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

Bayer’s new CEO was dealt a duo of ‘clearing events.’ T...

Nov 21, 2023

Opinion: STAT+: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs

Opinion: STAT+: The necessary roughness of 2023 has set...

Jan 20, 2024